Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...

UK-based startup Oyster Therapeutics has raised $60 million in first-round financing that will be used to advance its tau ...

Just a few months after being formed, China's Funnel Biosciences has signed a $2 billion-plus partnership with Third Rock ...

Notably, raising growth capital and strategic partnering remain the most common planned activities, while relatively few ...

The FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to the label of their products for a rare eye ...

Asundexian has been approved by the FDA under the Sunharbo brand name for use in combination with antiplatelet therapy to ...

The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...

More than ever, pharma firms are under increasing pressure to harness the power of AI, advanced analytics, and machine ...

Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...